Circadian variations of androstenedione, dehydroepiandrosterone sulfate and free testosterone in obese women with menstrual disturbances

Endocrine Regulations

Volumn 32, Issue 4, 1998, Pages 169-176

  Ostrowska, Z ^a   Zwirska Korczala, K ^b   Pardela, M ^b   Drozdz, M ^b   Kos Kudla, B ^b   Buntner, B ^b  

^a Silesian University of Medical Sciences   (Poland)

^b NONE

Author keywords

Androstenedione; Circadian variations; Dehydroepiandrosterone sulfate; Free testosterone; Obese women

Indexed keywords

EID: 0042656074     PISSN: 12100668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. BERNASCONI D, DEL MONTE P, MEOZZI M, RANDAZZO M, BADARACCO B, MARUGO M: The impact of obesity on hormonal parameters in hirsute and nonhirsute women. Metabolism 45, 72-75, 1996
2. BJORNTORP P: Metabolic implications of body fat distribution. Diabetes 14, 1132-1142, 1991
3. BJÖRNTORP P: Endocrine abnormalities of obesity. Metabolism 44 (Suppl 3), 21-23, 1995
4. th Annual Meeting-New Orleans, Abstracts, pp 834, 1988
5. BUFFINGTON CK, GIVENS JR, KITABCHI AE: Enhanced adrenocortical activity as a contributing factor to diabetes in hyperandrogenic women. Metabolism 43, 584-590, 1994
6. CLORE JN: Dehydroepiandrosterone and body fat. Obes Res 3 (Suppl 4), 613S-616S, 1995
7. CRAVE JC, FIMBEL S, LEJEUNE H, CUGNARDEY N, DECHAUD H, PUGEAT M: Effects of diet and met-formin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrin Metab 80, 2057-2060, 1995
8. DE PERGOLA G, TRIGGIANI V, GIORGINO F, COSPITE MR, GAR- RUTI G, CINARELLI M, GUASTAMACCHIA E, GIORGINO R: The free testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int J Obes Relat Metab Disord 18, 659-664, 1994
9. FENDRI S, ARIOT S, MARCFLLI JM, DUBREUIL A, LALAU JD: Relationship between insulin sensitivity and circulating sex hormone-binding globulin levels in hyperandrogenic obese women. Int J Obes Relat Metab Disord 18, 755-759, 1994
10. GIAGULLI VA, DE PERGOLA G, GIORGINO F, CINARELLI M, ABBATICCHIO G, VERMULEN A, GIORGINO R: Increased free testosterone but normal 5 alpha-reduced testosterone metabolities in obese premenopausal women. Clin Endocrin Oxf 36, 553-558, 1992
11. GLASS AR: Endocrine aspects of obesity. Med Clin North Am 73, 139-160, 1989
12. GUZIK DS, WING R, SMITH D, BERGA SL, WINTERS SJ: Endocrine consequence of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 61, 598-604, 1994
13. HALBERG F, TONG Y, JOHNSON EA: Circadian system phase as aspects of temporal morphology: procedure and illustrative examples. In: The Cellular Aspects of Biorhythms, Springer Verlag, Berlin (Ed. H von Mayerbach), pp 1-12, 1967
14. KIRSCHNFR MA, SAMOJLIK E, DREJKA M, SZMAL E, SCHNEIDER G, ERTEL N: Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrin Metab 70, 473-479, 1990
15. KISSEBACH AH, KRAKOWER GR: Regional adiposity and morbidity: Physiol Rev 74, 761-811, 1994
16. KITABCHI AE, BUFFINGTON CK, GIVENS J, INOUYE H: Role of adrenal and gonadal androgens in insulin action and metabolism. Nippon Naibunpi Gakkai Zasshi 20, 203-213, 1991
17. KURTZ BR, GIVENS JR, KOMINDR S, STEVENS MD, KARAS JG, BITTLE JB, JUDGE D, KITABCHI AE: Maintenance of normal circulating levels of delta 4-androstenedione and dehydroepiandrosterone in simple obesity despite increased metabolic clearance rates: evidence for a servo-control mechanism. J Clin Endocrin Metab 64, 1261-1267, 1987
18. LEENEN R, VAN DER KOOY K, SEIDEL JC: Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocr Metab 78, 1515-1520, 1994
19. LUTHOLD WW, BORGES MF, MARCONDES JA, HAKOHYAMA M, WAJCHENBERG BL, KIRSCHNER MA: Serum testosterone fractions in women: normal and abnormal clinical states. Metabolism 42, 638-643, 1993
20. MARCELLI JM, DEBUSSCHE X, FENDRI S, PUY H, ARTOL S: Female obesity: testosteronemia is positively correlated with peripheral insulin resistance. Ann Endocrin Paris 54, 169-173, 1993
21. MILEWICZ A: Steroid hormones and adipose tissue distribution. Pol Tyg Lek, Suppl 1, 28-32, 1995
22. NESTLER JE, STRAUSS JF: Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrin Metab Clin North Am 20, 807-823, 1991
23. OSTROWSKA Z, BUNTNER B, ZWIRSKA-KORCZALA K, PARDELA M, MAREK B, DROZDZ M.: Association between pituitary ovarian axis function and melatonin secretion during day/night cycle in morbidly obese women with upper body obesity and menstrual disturbances before and after jejunoileostomy. Bull Pol Ac Biol 43, 85-97, 1995a
24. OSTROWSKA Z, ZWIRSKA-KORCZALA K, BUNTNER B, PARDELA M, DROZDZ M.: Effect operative weight reduction on hypothalamo-pituitary, -adrenal and -ovarian axes function in obese women with menstrual disturbances. Endocrin Regul 29, 201-213, 1995b
25. SAMOJLIK E, KIRTSCHNER MA, SIBER D, SCHNEIDER G, ERTEL NH: Elevated production and metabolic clearance rates of androgens in morbidly obese women. J Clin Endocrin Metab 59, 949-954, 1984
26. SVACINA S, SONKA J, HAAS T: Dehydroepiandrosterone and insulinemia. Sbornik Lek 96, 303-306, 1995
27. TSCHERNOF A, LABRIE E, BÉLANGER A, DEPRÉS JP: Obesity and metabolic complications: contributions of dehydroepiandrosterone and other steroid hormones. J Endocrin 150, S155-S164, 1996
28. VAQUE J: Obesities. John Libbey, London, 1991
29. WEAVER JU, HOLLY JM, KOPELMAN PG, NOONAN K, GIADOM CG, WHITE N, VIRDEE S, WASS JA: Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrin 35, 97-102, 1991
30. ZUMOFF B: Hormonal abnormalities in obesity. Acta Med Scand Suppl 723, 153-160, 1988